Clovis Oncology, Inc. (NASDAQ:CLVS)
Clovis Oncology, Inc. (NASDAQ:CLVS) represented a move of 10.87 percent or $2.92 per share and closed its previous day trading session at $19.08. 9.15 Million Shares were traded in the last trading session with an Average Volume of 2.29 Million Shares. The stock currently has a Market Capitalization of 1.01 Billion.
Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.
The stock traded between $11.50 and $69.02 over 1-Year time period showing its price to sales ratio of 12.24. Clovis Oncology, Inc. (NASDAQ:CLVS) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-13.84 and 200-Day Simple Moving Average of $-53.17. Its Price to Free Cash Flow is 0 and Price to Book of 4.3.
Analyst’s recommended the stock as 2.3 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Clovis Oncology, Inc. (NASDAQ:CLVS) reported its Actual EPS of $-1.71/share. The analysts offering Earnings Estimates for the company were believing that Clovis Oncology, Inc. could bring EPS of $-1.6/share. The difference between Actual EPS and Estimated EPS was -0.11 Percent. Thus showing an Earnings Surprise of -6.9 Percent.
Hormel Foods Corporation (NYSE:HRL)
In the last trading session, Hormel Foods Corporation (NYSE:HRL) added its value by 1% closing at the price of $45.54. The stock currently has market capitalization of 24.35 Billion, with average volume of 3.02 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Hormel Foods Corporation (NYSE:HRL) is showing beta of 0.13. This particular value of beta suggests that Hormel Foods Corporation (NYSE:HRL) has historically moved 13% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Hormel Foods Corporation (NYSE:HRL) is at $1.71.
The stock currently has RSI of 63.18. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Hormel Foods Corporation is a global branded food company with across 75 countries worldwide. Its brands include SKIPPY, SPAM, Hormel Natural Choice, Applegate, Justin’s, Wholly Guacamole, Hormel Black Label and more than 30 other beloved brands. The company is a member of the S&P 500 Index and the S&P 500 Dividend Aristocrats, was named one of The 100 Best Corporate Citizens by Corporate Responsibility Magazine for the eighth year in a row, and has received numerous other awards and accolades for its corporate responsibility and community service efforts. The company announced its new vision for the future – Inspired People. Inspired Food – focusing on its legacy of innovation. Bringing high-quality branded products that are flavorful, nutritious and convenient puts us among the most trusted and well-known food companies in the world. Hormel Foods has brought innovation, beloved brands and outstanding value to their consumers, customers, communities and shareholders.
Hormel Foods Corporation (NYSE:HRL) topped its 52-week high price of $46.26 on 11/19/18 and 52-Week Low Price of $31.71 on 02/06/18. The Stock currently has P/E (price to earnings ttm) of 26.57 and Weekly volatility of 2.03% and monthly volatility of 2.00% respectively.